Comparative evaluation of urokinase‐type plasminogen activator receptor expression in primary breast carcinomas and on metastatic tumor cells
Data up to Jan 2025
Total Citations Per Year
Abstract
References (32)
New functions for the matrix metalloproteinases in cancer progression
2002 • 5,937 citations
[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].
1987 • 1,906 citations
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 • 1,561 citations
uPAR: a versatile signalling orchestrator
2002 • 1,175 citations
Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
2000 • 927 citations
Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal Status
1996 • 491 citations
Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for Therapy
1997 • 391 citations
Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study
1999 • 308 citations
Individual development and uPA–receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer
1995 • 253 citations
Epithelial Cells in Bone Marrow of Breast Cancer Patients at Time of Primary Surgery: Clinical Outcome During Long-Term Follow-Up
2001 • 203 citations
Cell‐induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2‐terminal domain of the urokinase receptor
1991 • 194 citations
Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma.
1993 • 192 citations
Simultaneous Immunohistochemical Detection of Tumor Cells in Lymph Nodes and Bone Marrow Aspirates in Breast Cancer and Its Correlation With Other Prognostic Factors
2001 • 173 citations
Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy
1997 • 158 citations
The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue.
1994 • 153 citations
Association of Tumor Angiogenesis With Bone Marrow Micrometastases in Breast Cancer Patients
1997 • 133 citations
Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissues
1996 • 114 citations
The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface.
1995 • 110 citations
Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels.
1993 • 102 citations
Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis
1996 • 95 citations
Immunohistochemical Expression of uPA, uPAR, and PAI-1 in Breast Carcinoma
2000 • 93 citations
Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases — A comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases
2000 • 80 citations
Urokinase plasminogen activator receptor (CD87) expression of tumor-associated macrophages in ductal carcinoma in situ, breast cancer, and resident macrophages of normal breast tissue
1999 • 69 citations
Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue.
1997 • 67 citations
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.
1994 • 60 citations
Untitled
2000 • 38 citations
Urokinase gene expression indicates early invasive growth in squamous cell lesions of the uterine cervix
1999 • 32 citations
Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistry
1998 • 30 citations
Urokinase type plasminogen activator receptor is a novel prognostic factor in breast cancer.
1997 • 24 citations
Validation of immunolocalization of the urokinase receptor expression in ductal carcinoma in situ of the breast: comparison with detection by non‐isotopic in‐situ hybridization
2000 • 17 citations
Urokinase-like Plasminogen Activator Receptor Expression on Disseminated Breast Cancer Cells
2001 • 17 citations
CD87-positive tumor cells in bone marrow aspirates identified by confocal laser scanning fluorescence microscopy.
1999 • 11 citations